MAP2K1 and melanoma: For example, curcumin exhibited synergistic anti-cancer effects in malignant melanoma cells in spheroid and 2D cultures when used in combination with binimetinib, a MEK1/2 inhibitor, through apoptosis, necroptosis, and ROS production.